n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine and Adenocarcinoma

n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Casero, RA; Davidson, NE; Hahm, HA; McCloskey, DE; Woster, PM	1

Reviews

1 review(s) available for n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine and Adenocarcinoma

Article	Year
Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment. Endocrine-related cancer, 1999, Volume: 6, Issue:1 Topics: Acetyltransferases; Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Division; Clinical Trials, Phase I as Topic; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Polyamines; Spermine; Tumor Cells, Cultured	1999

Article

Year

Clinical aspects of cell death in breast cancer: the polyamine pathway as a new target for treatment.

Endocrine-related cancer, 1999, Volume: 6, Issue:1

Topics: Acetyltransferases; Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Division; Clinical Trials, Phase I as Topic; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Polyamines; Spermine; Tumor Cells, Cultured

1999